Authors: Christopher Talbot1, Adam Webb1, Emily Harper1, David Azria2, Ananya Choudhury3, Dirk De Ruysscher4, Alison Dunning5, Rebecca Elliott3, Sarah Kerns6, Maarten Lambrecht7, Tiziana Rancati8, Barry Rosenstein9, Petra Seibold10, Elena Sperk11, Ana Vega12, Liv Veldeman13, Jenny Chang-Claude14, Catharine West3, Tim Rattay15, R. Paul Symonds16
1University of Leicester, Genetics, Leicester, United Kingdom; 2Montpellier Cancer Institute, Department of Radiation Oncology, Montpellier, France; 3University of Manchester, Division of Cancer Sciences, Manchester, United Kingdom; 4Maastricht University Medical Center, Department of Radiation Oncology (Maastro clinic), Maastricht, The Netherlands; 5University of Cambridge, Centre for Cancer Genetic Epidemiology, Cambridge, United Kingdom; 6University of Rochester, Department of Radiation Oncology , Rochester, NY, USA; 7UZ Leuven, Radiation Oncology, Leuven, Belgium; 8Fondazione IRCCS Istituto Nazionale dei Tumori, Prostate Cancer Program, Milano, Italy; 9Icahn School of Medicine at Mount Sinai, Department of Radiation Oncology, New York, USA; 10German Cancer Research Center (DKFZ), Division of Cancer Epidemiology, Heidelberg, Germany; 11Medical Faculty Mannheim, Department of Radiation Oncology, Mannheim, Germany; 12Fundación Pública Galega Medicina Xenómica, Instituto de Investigación Sanitaria, Santiago de Compostela, Spain; 13Ghent University Hospital, Department of Radiation Oncology, Ghent, Belgium; 14University Medical Center Hamburg-Eppendorf, University Cancer Center , Hamburg, Germany; 15University of Leicester, Leicester Cancer Research Centre, Leicester, United Kingdom; 16University of Leicester, Leicester Canceer Research Cenre, Leicester, United Kingdom
Show Affiliations
Hide Affiliations